No Detail Found!

In Vitro Efficacy of Doripenem against Pseudomonas Aeruginosa and Acinetobacter baumannii by E-test.

Author(s)
Mehreen Gilani Department of Microbiology, Army Medical College, Rawalpindi, Pakistan; National University of Sciences and Technology, Islamabad, Pakistan
Tehmina Munir Department of Microbiology, Army Medical College, Rawalpindi, Pakistan; National University of Sciences and Technology, Islamabad, Pakistan
Mahwish Latif Department of Microbiology, Army Medical College, Rawalpindi, Pakistan; National University of Sciences and Technology, Islamabad, Pakistan
Mehwish Gilani Department of Microbiology, Army Medical College, Rawalpindi, Pakistan; National University of Sciences and Technology, Islamabad, Pakistan
Sabahat Rehman Department of Microbiology, Army Medical College, Rawalpindi, Pakistan; National University of Sciences and Technology, Islamabad, Pakistan
Maliha Ansari Department of Microbiology, Army Medical College, Rawalpindi, Pakistan; National University of Sciences and Technology, Islamabad, Pakistan
Amira Hafeez Department of Microbiology, Army Medical College, Rawalpindi, Pakistan; National University of Sciences and Technology, Islamabad, Pakistan
Sara Najeeb Department of Microbiology, Army Medical College, Rawalpindi, Pakistan; National University of Sciences and Technology, Islamabad, Pakistan
Nadia Saad Department of Microbiology, Army Medical College, Rawalpindi, Pakistan; National University of Sciences and Technology, Islamabad, Pakistan
Abstract
Objective: To assess the in vitro efficacy of doripenem against Pseudomonas aeruginosa and Acinetobacter baumannii using Epsilometer strips. Study Design: Cross-sectional study. Place and Duration of Study: Department of Microbiology, Army Medical College, Rawalpindi and National University of Sciences and Technology, Islamabad, from May 2014 to September 2014. Methodology: A total of 60 isolates of Acinetobacter baumannii and Pseudomonas aeruginosa collected from various clinical samples received from Military Hospital were included in the study. The specimens were inoculated onto blood, MacConkey and chocolate agars. The isolates were identified using Gram staining, motility, catalase test, oxidase test and API 20NE (Biomeriux, France). Organisms identified as Acinetobacter baumannii and Pseudomonas aeruginosa were included in the study. Bacterial suspensions equivalent to 0.5 McFarland turbidity standard of the isolates were prepared and applied on Mueller Hinton agar. Epsilometer strip was placed in the center of the plate and incubated for 18-24 hours. Minimum Inhibitory Concentration (MIC) was taken to be the point where the epsilon intersected the E-strip. MIC of all the isolates was noted. Results: For Pseudomonas aeruginosa isolates, MIC50 was 12 µg/mL and MIC90 was 32 µg/mL. For Acinetobacter baumannii MIC50 and MIC90 was 32 µg/mL. Conclusion: Doripenem is no more effective against Pseudomonas aeruginosa and Acinetobacter baumannii in our setting.
Publication Details
Page(s) 726-729
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 25, Issue: 10, Year: 2015

Request the full text from PASTIC

References
LeblebiciogluH,CakirN,CelenM,KurtH,BarisH,LaeufferJ, 2012.Comparative activity of carbapenem testing (the COMPACT study) in Turkey,BMC Inf Dis 12 42 -
MartinezMJ,GarciaMI,SanchezGE,SanchezJE, 2010.Available carbapenems: properties and differences,Enferm Infecc Microbiol Clin 28 53 -64
SahmD., 2009.In vitro activity of doripenem,Clin Inf Dis 49 S11 -6
PatersonDL,DepestelDD, 2009.,Clin Inf Dis 49 291 -8
FirsovAA,GilbertD,GreerK,PortnoyYA,ZinnerSH, 2012.Comparative pharmacodynamics and antimutant potentials of doripenem and imipenem with ciprofloxacin-resistant Pseudomonas aeruginosa in an in vitro model,Antimicrob Agents Chemother 56 1223 -8
Wayne, 2014.8. Clinical and laboratory standards institute (CLSI). Performance standards for antimicrobial testing twenty fourth informational supplement,CLSI Document M100-S24 34 -
HojabriZ,Ahangarzadeh RezaeeM,NahaeiMR,SoroushMH,GhojazadehM,PirzadehT, 2013.Comparison of in vitro activity of doripenem versus old carbapenems against Pseudomonas aeruginosa clinical isolates from both CF and burn patients,Adv Pharma Bull 3 121 -5
KiratisinP,ChongthaleongA,TanTY,LagamayoE,RobertsS,GarciaJ, 2012.Comparative in vitro activity of carbapenems against major Gram-negative pathogens: results of AsiaPacific surveillance from the COMPACT II study,Int J Antimicrob Agents 39 311 -6
SomilyAM,AbsarMM,ArshadMZ,Al AskaAI,ShakoorZA,FataniAJ, 2012.Antimicrobial susceptibility patterns of multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii against carbapenems, colistin, and tigecycline,Saudi Med J 33 750 -5
DongSX,WangJT,ChangSC, 2012.Activities of doripenem against nosocomial bacteremic drug-resistant Gram-negative bacteria in a medical center in Taiwan,J Microbiol Immunol Infect 45 459 -64
MorrowBJ,PillarCM,DeaneJ,SahmDF,LynchAS,FlammRK, 2013.Activities of carbapenem and comparator agents against contemporary US Pseudomonas aeruginosa isolates from the CAPITAL surveillance program,Diagn Microbiol Inf Dis 75 412 -6
LeeH,KoKS,SongJH,PeckKR, 2011.Antimicrobial activity of doripenem and other carbapenems against gram-negative pathogens from Korea,Microb Drug Resist 17 37 -45
ValenzaG,SeifertH,Decker-BurgardS,LaeufferJ,MorrisseyI,MuttersR, 2012.Comparative activity of carbapenem testing (COMPACT) study in Germany,Int J Antimicrob Agents 39 255 -8
KortenV,SoyletirG,YalcinAN,OguncD,DokuzoguzB,EsenerH, 2011.Comparative evaluation of in vitro activities of carbapenems against gram-negative pathogens: Turkish data of COMPACT study,Mikrobiyol Bul 45 197 -209
LascolsC,LegrandP,MerensA,LeclercqR,Armand-LefevreL,DrugeonHB, 2011.In vitro antibacterial activity of doripenem against clinical isolates from French teaching hospitals: proposition of zone diameter breakpoints,Eur J Clin Microbiol Infect Dis 30 475 -82
JeanSS,HsuehPR,LeeWS,ChangHT,ChouMY,ChenIS, 2010.In vitro activities of doripenem and other carbapenems against clinically important bacteria isolated in intensive care units: nationwide data from the SMART Programme,Eur J Clin Microbiol Infect Dis 29 471 -5
MartiS,Sánchez-CéspedesJ,AlbaV,VilaJ., 2009.In vitro activity of doripenem against Acinetobacter baumannii clinical isolates,Int J Antimicrob Agents 33 181 -2
0

Citations

0

Downloads

75

Views